↓ Skip to main content

Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments

Overview of attention for article published in BMC Neurology, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments
Published in
BMC Neurology, April 2021
DOI 10.1186/s12883-021-02196-7
Pubmed ID
Authors

Dulanji K. Kuruppu, Joshua Tobin, Yan Dong, Sheena K. Aurora, Laura Yunes-Medina, A. Laine Green

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 7 15%
Other 4 9%
Researcher 4 9%
Student > Ph. D. Student 2 4%
Student > Bachelor 2 4%
Other 1 2%
Unknown 26 57%
Readers by discipline Count As %
Medicine and Dentistry 10 22%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Neuroscience 3 7%
Nursing and Health Professions 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 0 0%
Unknown 27 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2022.
All research outputs
#7,496,019
of 22,914,829 outputs
Outputs from BMC Neurology
#850
of 2,446 outputs
Outputs of similar age
#165,284
of 432,278 outputs
Outputs of similar age from BMC Neurology
#24
of 72 outputs
Altmetric has tracked 22,914,829 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,446 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,278 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.